BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Kalpit Patel does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 AVBPArriVent BioPharma, Inc. Common Stock | Buy | $37.00 | Mar 2025 | +11.9% | Miss |
 GERNGeron Corporation | Buy | $3.50 | Feb 2025 | −33.2% | Miss |
 VSTMVerastem Inc | Buy | $9.00 | Jan 2025 | +2.0% | Hit |
 FHTXFoghorn Therapeutics Inc | Buy | $10.00 | Jan 2025 | +29.1% | Miss |
 PDSBPDS Biotechnology Corp | Buy | $7.00 | Nov 2024 | −75.2% | Miss |
 CRBPCorbus Pharmaceuticals Holding | Buy | $40.00 | Sep 2024 | −29.2% | Miss |
| PDSBPDS Biotechnology Corp | Buy | $9.00 | Jun 2024 | −35.6% | Miss |
| PDSBPDS Biotechnology Corp | Buy | $11.00 | Mar 2024 | −68.9% | Miss |
 DERMJourney Medical Corp | Buy | $6.00 | Sep 2023 | +40.2% | Hit |
| DERMJourney Medical Corp | Buy | $6.00 | Jul 2023 | +205.5% | Hit |
| DERMJourney Medical Corp | Buy | $3.00 | May 2023 | +170.9% | Hit |
| DERMJourney Medical Corp | Buy | $6.00 | Mar 2023 | +95.8% | Hit |
 ENTXEntera Bio Ltd | Buy | $5.00 | Jul 2022 | −50.6% | Miss |
 INKTMink Therapeutics Inc | Buy | $10.00 | Jan 2022 | −33.7% | Miss |
 INABIn8bio Inc | Buy | $9.00 | Jan 2022 | −43.3% | Miss |
 DNTHDianthus Therapeutics Inc. | Buy | $6.00 | Jan 2022 | −90.8% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.